Artificial circRNAs inhibit the production of HCV viral proteins by effectively adsorbing cellular miR-122 (Jost et al., 2018), and the delivery of purified circRNAs can activate RIG-I-mediated immune responses and provides effective protection against viral infection (Chen Y. G. et al., 2017). Here, RIGI is linked to viral infectious disease.